What Factors Influence CTS Surgery Decisions in Black Patients?
-
By
-
Andrea Surnit
-
June 5, 2026
-
4 min
By
Andrea Surnit
June 5, 2026
Phase 3 findings showed longer median progression-free survival with zanidatamab-containing regimens vs trastuzumab plus chemotherapy.
August 25, 2026
National survey data found lower per-capita representation across 23 occupations in nonmetropolitan communities, with the largest workforce differences observed among psychologists, physicians, and surgeons.
June 11, 2026
A randomized trial found similar short-term morbidity and 12-month functional outcomes with both approaches, while highlighting the need to balance perfusion with a tension-free anastomosis.
July 15, 2026